CVM
$3.60
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has complete...
Recent News
Cel-Sci: Fiscal Q1 Earnings Snapshot
VIENNA, Va. AP) — Cel-Sci Corp. CVM) on Tuesday reported a loss of $5.5 million in its fiscal first quarter.
Cel-Sci: Fiscal Q3 Earnings Snapshot
VIENNA, Va. AP) — Cel-Sci Corp. CVM) on Thursday reported a loss of $5.7 million in its fiscal third quarter.
Cel-Sci: Fiscal Q2 Earnings Snapshot
VIENNA, Va. AP) — Cel-Sci Corp. CVM) on Wednesday reported a loss of $6.6 million in its fiscal second quarter.